Meflin/ ISLR is a marker of adipose stem and progenitor cells in mice and humans that suppresses white adipose tissue remodeling and fibrosis
Genes to Cells · 2024
DOI: 10.1111/gtc.13154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, 2024. Verfasst von Toshikazu Ishihara und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Immunoglobulins, Adipose Tissue, White, Mesenchymal Stem Cells, Metabolic Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development, Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
Identifying specific markers of adipose stem and progenitor cells (ASPCs) in vivo is crucial for understanding the biology of white adipose tissues (WAT). PDGFRα‐positive perivascular stromal cells represent the best candidates for ASPCs. This cell lineage differentiates into myofibroblasts that contribute to the impairment of WAT function. However, ASPC marker protein(s) that are functionally crucial for maintaining WAT homeostasis are unknown. We previously identified Meflin as a marker of mesenchymal stem cells (MSCs) in bone marrow and tissue‐resident perivascular fibroblasts in various tissues. We also demonstrated that Meflin maintains the undifferentiated status of MSCs/fibroblasts. Here, we show that Meflin is expressed in WAT ASPCs. A lineage‐tracing experiment showed that Meflin + ASPCs proliferate in the WAT of obese mice induced by a high‐fat diet (HFD), while some of them differentiate into myofibroblasts or mature adipocytes. Meflin knockout mice fed an HFD exhibited a significant fibrotic response as well as increases in adipocyte cell size and the number of crown‐like structures in WAT, accompanied by impaired glucose tolerance. These data suggested that Meflin expressed by ASPCs may have a role in reducing disease progression associated with WAT dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Immunometabolism, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Molecular Medicine and Metabolism, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan.
- Center for Cardiovascular Research, University of Hawaii at Manoa, Honolulu, Hawaii, USA.
- Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
ORCID-Profile: Shinji Mii, Atsushi Enomoto
Förderung
- Japan Agency for Medical Research and Development
- Ministry of Education, Culture, Sports, Science and Technology
Zitieren
APA
Ishihara, T., Kato, K., Matsumoto, K., Tanaka, M., Hara, A., Shiraki, Y., Morisaki, H., Urano, Y., Ando, R., Ito, K., Mii, S., Esaki, N., Furuhashi, K., Takefuji, M., Suganami, T., Murohara, T., & Enomoto, A. (2024). Meflin/ ISLR is a marker of adipose stem and progenitor cells in mice and humans that suppresses white adipose tissue remodeling and fibrosis. Genes to Cells. https://doi.org/10.1111/gtc.13154
Vancouver
Ishihara T, Kato K, Matsumoto K, Tanaka M, Hara A, Shiraki Y, et al. Meflin/ ISLR is a marker of adipose stem and progenitor cells in mice and humans that suppresses white adipose tissue remodeling and fibrosis. Genes to Cells. 2024. doi:10.1111/gtc.13154
BibTeX
@article{Ishihara2024,
author = {Ishihara, Toshikazu and Kato, Katsuhiro and Matsumoto, Kotaro and Tanaka, Miyako and Hara, Akitoshi and Shiraki, Yukihiro and Morisaki, Hidenori and Urano, Yuya and Ando, Ryota and Ito, Kisuke and Mii, Shinji and Esaki, Nobutoshi and Furuhashi, Kazuhiro and Takefuji, Mikito and Suganami, Takayoshi and Murohara, Toyoaki and Enomoto, Atsushi},
title = {Meflin/ ISLR is a marker of adipose stem and progenitor cells in mice and humans that suppresses white adipose tissue remodeling and fibrosis},
journal = {Genes to Cells},
year = {2024},
doi = {10.1111/gtc.13154}
}
EUVIMED